關鍵詞： GSK A*STAR 合作協(xié)議
2013年4月10日訊 /生物谷BIOON/ --制藥巨頭GlaxoSmithKline公司與新加坡的A*STAR下屬的Institute of Chemical and Engineering Sciences（ICES）達成一項為期五年的研發(fā)合作協(xié)議。該合作將集中在研究新型定制藥物領域。
GSK和A*STAR合作已達十年之久,，ICES的Dr Keith Carpenter表示與GSK的合作能夠加強公司在研發(fā)方面的實力,。（生物谷Bioon.com）
詳細英文報道：
Pharma giant GlaxoSmithKline ($GSK) has inked a 5-year research pact with A*STAR's Institute of Chemical and Engineering Sciences (ICES) in Singapore, promising to collaborate on researching newly formulated drugs. The two groups have been working together for the past decade, helping build the city-state's reputation for R&D. "Collaborating with GSK, a global leader in pharmaceuticals and healthcare provides an opportunity for us to further our research and deepen our capabilities in formulation science with skilled scientists and technical expertise. This venture will enable us to develop future scientists and laboratory analysts with the right skills to grow this industry in Singapore," said Dr Keith Carpenter, the executive director of ICES.
